1. Home
  2. NINE vs PMN Comparison

NINE vs PMN Comparison

Compare NINE & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nine Energy Service Inc.

NINE

Nine Energy Service Inc.

HOLD

Current Price

$0.49

Market Cap

27.5M

Sector

Energy

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$7.91

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NINE
PMN
Founded
2011
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Pharmaceuticals and Biotechnology
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
23.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NINE
PMN
Price
$0.49
$7.91
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
1.0M
41.7K
Earning Date
10-30-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$571,171,000.00
N/A
Revenue This Year
$4.56
N/A
Revenue Next Year
$1.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.59
N/A
52 Week Low
$0.37
$6.27
52 Week High
$1.78
$39.75

Technical Indicators

Market Signals
Indicator
NINE
PMN
Relative Strength Index (RSI) 50.39 96.32
Support Level $0.42 $0.29
Resistance Level $0.49 $7.95
Average True Range (ATR) 0.04 0.39
MACD 0.01 0.80
Stochastic Oscillator 83.29 97.13

Price Performance

Historical Comparison
NINE
PMN

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: